Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2006 | |
| Sales | 6,085 | 0 | 0 |
| Gross Profit | 6,085 | N/A | N/A |
| Operating Expenses | 17,400 | 8,904 | 0 |
| Operating Income | -11,315 | -8,904 | N/A |
| Other Income | 20 | -1,443 | 0 |
| Pre-tax Income | -11,295 | -10,347 | 0 |
| Net Income Continuous | -11,295 | -10,347 | N/A |
| Net Income | $-11,295 | $-10,347 | $N/A |
| EPS Basic Total Ops | -480.25 | -486.00 | N/A |
| EPS Basic Continuous Ops | -470.79 | -485.88 | N/A |
| EPS Diluted Total Ops | -480.25 | -486.00 | N/A |
| EPS Diluted Continuous Ops | -470.79 | -485.88 | N/A |
| EBITDA(a) | $-11,229 | $-8,885 | $N/A |